FBLN1 and atherosclerosis: Although definite mechanisms on fibulin-1′s role in extracellular matrix remodelling, especially in clinical situations such as type 2 diabetes, atherosclerosis, cardiac ischemia and heart failure, remain to be elucidated, some evidence exists indicating its role in some of these conditions [8], [11].